Understanding the relationship between circulating ghrelin and weight change induced by a lifestyle intervention in overweight or obese breast cancer survivors may be informative for developing and adapting existing sustainable weight loss programming for this population. The gene discussed is GHRL; the disease is breast carcinoma.